A new study published in the British Medical Journal found that a common class of bone drugs called Bisphosphonates (Fosamax, Boniva, Reclast and Actonel) increase the risk for esophageal cancer, perhaps even doubling it. With this is mind, I wanted to focus on supporting bone health from a supplemental perspective. [...]
